June 30, 2020 / 09:40 AM IST
Reported Standalone quarterly numbers for Venmax Drugs and Pharmaceuticals are:Net Sales at Rs 0.11 crore in March 2020 up 6.71% from Rs. 0.10 crore in March 2019.
Story continues below Advertisement
Quarterly Net Loss at Rs. 0.11 crore in March 2020 up 44.44% from Rs. 0.21 crore in March 2019.
EBITDA stands negative at Rs. 0.12 crore in March 2020 up 40% from Rs. 0.20 crore in March 2019.
Venmax Drugs shares closed at 4.18 on March 19, 2018 (BSE)
Venmax Drugs and Pharmaceuticals | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'20 | Dec'19 | Mar'19 | Net Sales/Income from operations | 0.11 | 0.16 | 0.10 | Other Operating Income | -- | -- | -- | Total Income From Operations | 0.11 | 0.16 | 0.10 | EXPENDITURE | Consumption of Raw Materials | -- | -- | 0.04 | Purchase of Traded Goods | 0.12 | 0.12 | -- | Increase/Decrease in Stocks | -0.06 | 0.07 | 0.03 | Power & Fuel | -- | -- | -- | Employees Cost | 0.09 | 0.05 | 0.06 | Depreciation | 0.00 | 0.00 | 0.00 | Excise Duty | -- | -- | -- | Admin. And Selling Expenses | -- | -- | -- | R & D Expenses | -- | -- | -- | Provisions And Contingencies | -- | -- | -- | Exp. Capitalised | -- | -- | -- | Other Expenses | 0.08 | 0.06 | 0.16 | P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.12 | -0.14 | -0.20 | Other Income | -- | -- | 0.00 | P/L Before Int., Excpt. Items & Tax | -0.12 | -0.14 | -0.20 | Interest | 0.00 | 0.00 | -- | P/L Before Exceptional Items & Tax | -0.12 | -0.14 | -0.20 | Exceptional Items | -- | -- | -- | P/L Before Tax | -0.12 | -0.14 | -0.20 | Tax | 0.00 | 0.00 | 0.01 | P/L After Tax from Ordinary Activities | -0.11 | -0.14 | -0.21 | Prior Year Adjustments | -- | -- | -- | Extra Ordinary Items | -- | -- | -- | Net Profit/(Loss) For the Period | -0.11 | -0.14 | -0.21 | Equity Share Capital | 5.24 | 5.24 | 5.24 | Reserves Excluding Revaluation Reserves | -- | -- | -- | Equity Dividend Rate (%) | -- | -- | -- | EPS Before Extra Ordinary | Basic EPS | -0.22 | -0.27 | -0.39 | Diluted EPS | -0.22 | -0.27 | -0.39 | EPS After Extra Ordinary | Basic EPS | -0.22 | -0.27 | -0.39 | Diluted EPS | -0.22 | -0.27 | -0.39 | Public Share Holding | No Of Shares (Crores) | -- | -- | -- | Share Holding (%) | -- | -- | -- | Promoters and Promoter Group Shareholding | a) Pledged/Encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | b) Non-encumbered | - Number of shares (Crores) | -- | -- | -- | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | Source : Dion Global Solutions Limited |
|
Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!